Tvardi Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2014 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tvardi Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2014 to Q1 2025.
  • Tvardi Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 6, 2025 was 4.57M shares, a 91.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 4.57M -50.1M -91.6% Mar 6, 2025 10-K 2025-03-11
Q3 2024 54.9M +375K +0.69% Nov 11, 2024 10-Q 2024-11-14
Q2 2024 54.8M +769K +1.42% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 54.7M +713K +1.32% Mar 1, 2024 10-K 2024-03-06
Q3 2023 54.5M +747K +1.39% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 54.1M +352K +0.66% Aug 3, 2023 10-Q 2023-08-07
Q1 2023 53.9M +352K +0.66% Mar 2, 2023 10-K 2023-03-06
Q3 2022 53.7M +275K +0.51% Nov 3, 2022 10-Q 2022-11-07
Q2 2022 53.7M +3.64M +7.26% Aug 4, 2022 10-Q 2022-08-08
Q1 2022 53.6M +3.54M +7.07% May 5, 2022 10-Q 2022-05-09
Q3 2021 53.5M +3.63M +7.28% Nov 4, 2021 10-Q 2021-11-08
Q2 2021 50.1M +3.2M +6.83% Aug 5, 2021 10-Q 2021-08-09
Q1 2021 50.1M +3.33M +7.12% May 6, 2021 10-Q 2021-05-10
Q3 2020 49.8M +3.15M +6.76% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 46.9M +469K +1.01% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 46.7M +7.18M +18.1% Feb 24, 2020 10-K 2020-02-27
Q3 2019 46.7M +7.23M +18.3% Nov 1, 2019 10-Q 2019-11-05
Q2 2019 46.4M +7.13M +18.1% Aug 2, 2019 10-Q 2019-08-07
Q1 2019 39.5M +6.86M +21% Mar 5, 2019 10-K 2019-03-12
Q3 2018 39.4M +6.84M +21% Nov 1, 2018 10-Q 2018-11-06
Q2 2018 39.3M +6.71M +20.6% Aug 1, 2018 10-Q 2018-08-07
Q1 2018 32.7M +183K +0.56% Mar 8, 2018 10-K 2018-03-15
Q3 2017 32.6M +5.33M +19.5% Oct 27, 2017 10-Q 2017-11-02
Q2 2017 32.6M +5.3M +19.4% Jul 28, 2017 10-Q 2017-08-03
Q1 2017 32.5M +5.25M +19.3% Apr 28, 2017 10-Q 2017-05-04
Q3 2016 27.3M +51.3K +0.19% Oct 28, 2016 10-Q 2016-11-04
Q2 2016 27.3M +118K +0.43% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 27.3M +4.43M +19.4% Mar 3, 2016 10-K 2016-03-11
Q3 2015 27.2M +4.45M +19.5% Nov 4, 2015 10-Q 2015-11-09
Q2 2015 27.2M +4.52M +20% Aug 5, 2015 10-Q 2015-08-10
Q1 2015 22.8M +223K +0.99% Mar 20, 2015 10-K 2015-03-27
Q3 2014 22.8M Nov 5, 2014 10-Q 2014-11-10
Q2 2014 22.6M Aug 5, 2014 10-Q 2014-08-07
Q1 2014 22.6M May 5, 2014 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.